Antibiotic resistance is a growing concern – from human health to crop survival. A new study successfully uses nanogels to target and almost entirely inhibit the bacteria P. Aeruginosa.
Recently published in Angewandte Chemie, the study demonstrates 99.9 % effective inhibition against P. Aeruginosa, a particularly evasive bacterium.
By combining pathogen-specific sugar ligands with a membrane-disrupting antimicrobial peptide, the system shows strong efficacy against both planktonic bacteria and established biofilms: two environments where conventional antibiotics often fail.
P. aeruginosa is a leading cause of hospital-acquired infections, especially in immunocompromised patients. Its ability to form biofilms enables it to evade antibiotics and immune responses.
In this study, nanogels are presented as a promising workaround to this challenge. Their tunable structures support multifunctionality, making them suitable for carrying therapeutic agents and enabling multivalent interactions that enhance microbial targeting.
The researchers constructed their nanogels using dendritic polyglycerols (dPGs) functionalized with two sugars: fucose (Fuc) and galactose (Gal) ligands. The sugars bind to the P. aeruginosa lectins LecB and LecA, and are then integrated into the antibacterial peptide BMAP-18 (GRFKRFRKKFKKLFKKLS), known for its membrane-disrupting activity.
This framework hopes to break down the protective membrane that enables P. aeruginosa to thrive despite other antibiotics, and then inhibit the bacterial almost completely.
The nanogels were synthesized using photo-induced thiolene crosslinking of norbornene and thiol-bearing dPG macromonomers using inverse nanoprecipitation.
Among several different formulations, NG0.33 (the nanogel formulation with a 33 % macromonomer ratio) exhibited the strongest intrinsic binding to bacteria. The researchers attribute this success to the optimized flexibility, making it the chosen scaffold for further modification.
After conjugation with sugars and BMAP-18, nanogel size increased from 47 nm to about 80 nm, and zeta potential rose from +35 mV to +45 mV, confirming successful functionalization.
Importantly, the nanogels remained structurally stable across infection-relevant pH values (5.0-7.0) for at least five days.
Near Perfect Performance Against Planktonic Cells and Biofilms
The sugar-modified nanogels showed higher affinity for both planktonic and biofilm-associated P. aeruginosa in flow cytometry and fluorescence microscopy assays. Significantly, the results of the study showed that adding BMAP-18 did not interfere with lectin binding.
At just 8 µg/mL, the peptide-sugar nanogels (PNG0.33-Fuc/Gal) inactivated over 99.99 % of planktonic bacteria within 12 hours and maintained continued bactericidal activity for more than 72 hours.
Control experiments also demonstrated that sugar-only nanogels could initially reduce bacterial survival, but bacteria resumed growth over time, highlighting the need for a combined targeting-and-killing strategy.
For biofilms, the same nanogels achieved near-complete matrix removal after 72 hours of co-incubation and reduced the thickness of mature 72-hour biofilms by 65 % after a 12-hour treatment, performance comparable to tobramycin.
More than 99.9 % of the biofilm-embedded P. aeruginosa cells were inactivated, indicating efficient penetration and disruption of the biofilm structures.
Broad-Spectrum Potential and Biocompatibility
The nanogels were also effective in inhibiting other bacterial growth: they achieved approximately 90 % inhibition of E. coli and MRSA at higher doses (32 µg/mL and 16 µg/mL, respectively).
This activity likely reflects the higher natural affinity of galactose for lectins in these bacteria, combined with BMAP-18’s membrane activity.
Biocompatibility tests demonstrated over 80 % fibroblast viability at concentrations up to 1 mg/mL, with no measurable hemolysis, indicating a favorable safety profile for further preclinical exploration.
A Modular Platform for Next-Generation Antimicrobials
By integrating lectin-targeting sugars with a potent antimicrobial peptide, the heteromultivalent nanogels address weaknesses of single-function systems and highlight the advantages of combining selective recognition with sustained bactericidal action.
Their modularity suggests they could be adapted to target other pathogens by varying ligand or peptide components.
Future work will first need to evaluate in vivo performance, as well as manufacturing scalability and expanded ligand-peptide combinations.
As antibiotic resistance continues to rise, such customizable nanogel systems are a compelling first step in anti-infective medicines.
Journal Reference
Yuhang, J.D., et al. (2025, November). Heteromultivalent Nanogels as Highly Potent Inhibitors of Pseudomonas Aeruginosa. Angewandte Chemie International Edition, e13121. DOI: 10.1002/anie.202513121
News
Your Voice May Reveal How Fast Your Brain Is Aging
Researchers have developed a machine-learning “speech clock” that estimates age from subtle patterns in how people speak and what they say. It is possible that people’s voices may contain certain signals of aging that [...]
Optogenetics Pioneers Win 2026 Nobel Prize in Physiology or Medicine
The 2026 Nobel Prize in Physiology or Medicine has been awarded to Peter Hegemann, Georg Nagel, and Karl Deisseroth for the development of optogenetics, a revolutionary technology that uses light to control individual neurons [...]
Molecular Manufacturing: The Future of Nanomedicine – From NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
What is ‘American Covid’ and how bad is it?
Cases of so-called ‘American Covid’ are on the rise in the UK. The strain is officially called XFG, or ‘Stratus’, and is the most common variant in North America, hence the name. It might soon [...]
Researcher at Russian plague laboratory dies of ‘unknown’ infection
Russian authorities have imposed "anti-epidemic measures" after a laboratory worker at an institute in Siberia dedicated to studying the plague and other infectious diseases died of a mysterious illness. The researcher, a 28-year-old female [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
A Surprising Brain Signal Could Explain Why Eating Less Protein Extends Lifespan
A new paper suggests that limiting protein intake triggers a coordinated response throughout the body that may help explain how protein restriction affects healthy aging. Animals respond to protein restriction, or reduced protein in [...]
Back and shoulder surgery is often worse than useless
Millions of operations should be scrapped SIX IN TEN Britons have surgery at some point. So do lots of Americans, at a cost of perhaps $500bn a year, a third of all spending on [...]
Cocaine plays with mind, hijacks brain circuit, drives increasingly rigid and repetitive behavior
Researchers have found that cocaine hijacks brain circuit, which to drive increasingly rigid and repetitive behavior. The brain circuit that normally participates in selecting natural mouth and face movements, but which becomes disproportionately engaged [...]
Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma
The brain cancer glioblastoma is one of the most aggressive and treatment-resistant cancers known to medicine, carrying a median survival of just 12-15 months, even with the best available care. Now, researchers at the [...]
New Treatment Cuts “Bad” Cholesterol in Half for a Full Year
A single infusion of an experimental CRISPR-Cas9 therapy was reported to safely lower LDL cholesterol by 52.5% and triglycerides by 47.8%, as measured 12 months after treatment. What if one infusion could keep cholesterol [...]
Too Much RNA Can Drain a Cell’s Energy, Scientists Discover
A virus may cripple a cell’s power supply simply by producing too much of a molecule the cell needs to survive. New research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences [...]
West African scientists warn of weakening health systems and urge stronger outbreak detection
LOME, Togo (AP) — West African laboratory scientists called on governments Friday to strengthen capacity to detect disease outbreaks to avoid another major outbreak, saying health systems across the region are becoming weaker. Participants [...]
A Little-Known Protein Could Point to a New Way To Treat Alzheimer’s
A study suggests that increasing SORLA protein levels could help treat Alzheimer’s disease and other disorders involving tau protein. Increasing SORLA, a protein with a protective role in the brain, helped mice withstand damage [...]
Cancer’s Hidden Antioxidant Shield Helps It Escape the Immune System
Blocking an antioxidant protein that tumors use to suppress immune attacks improved cancer immunotherapy responses in mice. Cancer cells can release antioxidants that interfere with the immune cells trying to kill them. Researchers have [...]
Scientists Find a Berry Compound That Helps Muscle Cells Burn Fat
Pterostilbene, a compound found naturally in some foods, affects how skeletal muscles process fats by stabilizing a protein called PPARδ and increasing its signaling activity. Pterostilbene, a natural compound found in blueberries, grapes, and [...]
